TITLE

Soluble Urokinase Plasminogen Activator Receptor as a Marker for Use of Antidepressants

AUTHOR(S)
Haastrup, Eva; Grau, Katrine; Eugen-Olsen, Jesper; Thorball, Christian; Kessing, Lars Vedel; Ullum, Henrik
PUB. DATE
October 2014
SOURCE
PLoS ONE;Oct2014, Vol. 9 Issue 10, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Objectives: Inflammation is involved in the pathogenesis of depression. A few cross-sectional population-based studies have found that depression is associated with increased levels of inflammatory markers. Soluble urokinase plasminogen activation receptor (suPAR) is known to be a stable marker for inflammation. We investigated the bidirectional association between suPAR levels and use of antidepressants. Methods: suPAR level was measured in 9305 blood donors and analysed in relation to 5-years follow-up data on purchase of antidepressants and hospital diagnoses of depression from a nationwide Danish register. Results: For men and women without prior use of antidepressants we found a significantly higher risk for incident use of antidepressants with higher suPAR values. For men, the risk of first use of antidepressants increased by 72% from the 1st to the 4th quartile (HR = 1.72, 95% CI: 1.11–2.69). For women, it increased by 108% from the 1st to the 4th quartile (HR = 2.08, 95% CI: 1.45–2.98). Previous use of antidepressants was also significantly associated with higher suPAR levels (p = 0.002). Conclusions: High suPAR levels are associated with an increased risk for both previous and future use of antidepressants in healthy men and women. High suPAR are also associated with increased risk for a hospital diagnosis of depression.
ACCESSION #
99200859

 

Related Articles

  • NT-proBNP, C-Reactive Protein and Soluble uPAR in a Bi-Ethnic Male Population: The SAfrEIC Study. Kruger, Ruan; Schutte, Rudolph; Huisman, Hugo W.; Hindersson, Peter; Olsen, Michael H.; Eugen-Olsen, Jesper; Schutte, Aletta E. // PLoS ONE;Mar2013, Vol. 8 Issue 3, p1 

    Objective and design: This cross-sectional study aimed to investigate associations between a marker of cardiac strain, the N-terminal prohormone B-type natriuretic peptide (NT-proBNP), and inflammation as reflected by either a conventional or novel inflammatory marker in a bi-ethnic South...

  • suPAR as a prognostic biomarker in sepsis.  // BMC Medicine;2012, Vol. 10 Issue 1, p2 

    The article offers information on a study conducted on soluble urokinase-type plasminogen activator receptor (suPAR), which can be used as a prognostic biomarker in sepsis. It states that suPAR expression is increased on peripheral blood mononuclear cells as on granulocytes and monocytes. It...

  • Tissue Plasminogen Activator in Psoriasis. Jensen, Pamela J.; Baird, Janet; Belin, Dominique; Vassalli, Jean-Dominique; Busso, Nathalie; Gubler, Pascale; Lazarus, Gerald S. // Journal of Investigative Dermatology;Nov90, Vol. 95 Issue 5, p13S 

    Elevated levels of the serine proteinase plasminogen activator are observed in psoriatic lesions. In contrast to normal epidermis, lesional psoriatic epidermis contains primarily tissue type plasminogen activator (tPA) activity and much lower levels of urokinase type plasminogen activator (uPA)...

  • Beneficial and Detrimental Effects of Plasmin(ogen) during Infection and Sepsis in Mice. Yongzhi Guo; Jinan Li; Hagström, Elin; Tor Ny // PLoS ONE;2011, Vol. 6 Issue 9, p1 

    Plasmin has been proposed to be an important mediator during inflammation/infection. In this study, by using mice lacking genes for plasminogen, tissue-type plasminogen activator (tPA), and urokinase-type PA (uPA), we have investigated the functional roles of active plasmin in infection and...

  • Negative regulation of urokinase-type plasminogen activator production through FGF-2-mediated activation of phosphoinositide 3-kinase. Mochizuki, Yasushi; Tsuda, Satoshi; Kanetake, Hiroshi; Kanda, Shigeru // Oncogene;10/10/2002, Vol. 21 Issue 46, p7027 

    Presents a study that examined the signal transduction pathways involved in the regulation of urokinase-type plasminogen activator (uPA) production by fibroblast growth factor (FGF)-2 treatment. Upregulation of uPA production in murine brain capillary endothelial cells; Enhancement of...

  • Correction.  // Gut;Sep2015, Vol. 64 Issue 9, p1465 

    A correction to the article "The urokinase plasminogen activator receptor (uPAR) controls macrophage phagocytosis in intestinal inflammation" that was published in a previous issue is presented.

  • DOES UPA ACTIVITY INCREASE AFTER PARTIAL HEPATECTOMY IN HUMANS? Smith, K.A.; Majeed, A.W.; Mangnall, D. // Gut;Apr2003 Supplement 1, Vol. 52, pA104 

    Introduction: An increase in the activity of the urokinase like plasminogen activator (uPA) has been recorded almost immediately after partial hepatectomy in rats but not confirmed in humans. Aims: To determine whether changes in uPA activity occur in humans immediately after hepatectomy....

  • Unchanged Plasma Levels of the Soluble Urokinase Plasminogen Activator Receptor in Elective Coronary Artery Bypass Graft Surgery Patients and Cardiopulmonary Bypass Use. Gozdzik, Waldemar; Adamik, Barbara; Gozdzik, Anna; Rachwalik, Maciej; Kustrzycki, Wojciech; Kübler, Andrzej // PLoS ONE;Jun2014, Vol. 9 Issue 6, p1 

    Objective and Design: The soluble urokinase plasminogen activator receptor (suPAR) has been recently recognized as a potential biological marker of various disease states, but the impact of a major surgical intervention on the suPAR level has not yet been established. The aim of our study was to...

  • Extracellular Matrix Biomarker, Fibulin-1, Is Closely Related to NT-proBNP and Soluble Urokinase Plasminogen Activator Receptor in Patients with Aortic Valve Stenosis (The SEAS Study). Kruger, Ruan; Rasmussen, Lars M.; Argraves, William S.; Eugen-Olsen, Jesper; Nielsen, Olav W.; Blyme, Adam; Willenheimer, Ronnie; Wachtell, Kristian; Olsen, Michael H. // PLoS ONE;Jul2014, Vol. 9 Issue 7, p1 

    Background: Fibulin-1, a circulating extracellular matrix glycoprotein, has been associated with arterial disease and elevated N-terminal prohormone B-type natriuretic peptide (NT-proBNP) in diabetes. Soluble urokinase plasminogen activator receptor (suPAR), a marker of inflammation, has been...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics